Halcinonide |
|
| Trade names | Halog |
|---|
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
|---|
| MedlinePlus | a682272 |
|---|
Routes of administration | Topical |
|---|
| ATC code | |
|---|
|
| Legal status |
|
|---|
|
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-6b-(chloroacetyl)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
|
| CAS Number | |
|---|
| PubChem CID | |
|---|
| DrugBank | |
|---|
| ChemSpider | |
|---|
| UNII | |
|---|
| ChEMBL | |
|---|
| CompTox Dashboard (EPA) | |
|---|
| ECHA InfoCard | 100.019.490 |
|---|
|
| Formula | C24H32ClFO5 |
|---|
| Molar mass | 454.96 g·mol−1 |
|---|
| 3D model (JSmol) | |
|---|
ClCC(=O)[C@]45OC(O[C@@H]5C[C@@H]2[C@@]4(C[C@H](O)[C@]3(F)[C@@]1(/C(=C\C(=O)CC1)CC[C@@H]23)C)C)(C)C
|
InChI=1S/C24H32ClFO5/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,26)17(28)11-22(16,4)24(19,31-20)18(29)12-25/h9,15-17,19,28H,5-8,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1 NKey:MUQNGPZZQDCDFT-JNQJZLCISA-N N
|
N Y (what is this?) (verify) |
Halcinonide is a high potency corticosteroid, in group II (second most potent group) under US classification.[1] It is used topically (in a 0.05% cream provided as Halog) in the treatment of certain skin conditions. It is available as a generic medication.[2]
References
Glucocorticoids and antiglucocorticoids (D07, H02) |
|---|
| Glucocorticoids | |
|---|
| Antiglucocorticoids | |
|---|
| Synthesis modifiers | |
|---|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Glucocorticoid receptor modulators
- Mineralocorticoids and antimineralocorticoids
- List of corticosteroids
|
Glucocorticoid receptor modulators |
|---|
| GRTooltip Glucocorticoid receptor | | Agonists |
- Others/atypical (other expanded steroid ring systems, homosteroids, and non-pregnane steroids): Cortisuzol
- Cortivazol
- Domoprednate
- Naflocort
- Nicocortonide
- Nivacortol (nivazol)
- Oxisopred
- RU-26988
- RU-28362
- Nonsteroidal glucocorticoids: AZD-5423
- GSK-9027
|
|---|
Mixed (SEGRMsTooltip Selective glucocorticoid receptor agonists) |
- Dagrocorat
- Fosdagrocorat
- Mapracorat
|
|---|
| Antagonists |
- 7α-Hydroxy-DHEA
- 17α-Methylprogesterone
- Aglepristone
- Asoprisnil
- Asoprisnil ecamate
- C108297
- C113176
- CORT-108297
- Cyproterone acetate
- Dazucorilant
- Exicorilant (CORT-125281)
- Guggulsterone
- Ketoconazole
- Lilopristone
- LLY-2707
- Metapristone (RU-42633)
- Miconazole
- Mifepristone (RU-486)
- Miricorilant (CORT-118335)
- Onapristone
- ORG-34116
- ORG-34517 (SCH-900636)
- ORG-34850
- Pregnenolone 16α-carbonitrile
- Relacorilant (CORT-125134)
- RTI 3021–012
- RTI 3021–022
- Telapristone
- Tibolone
- Toripristone
- Ulipristal acetate
- Zavacorilant
|
|---|
| Others |
- Antisense oligonucleotides: IONIS-GCCRRx (ISIS-426115)
|
|---|
|
|---|
- See also
- Receptor/signaling modulators
- Glucocorticoids and antiglucocorticoids
- Mineralocorticoid receptor modulators
- List of corticosteroids
|